Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

Data as of Jan 28
 -0.0115 / -1.55%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Rexahn Pharmaceuticals, Inc. is a development stage biopharmaceutical company dedicated to the discovery, development and commercialization of innovative treatments for cancer and other medical needs. The company currently has three clinical stage oncology candidates, Archexin, RX-3117, and Supinoxin and a robust pipeline of preclinical compounds to treat multiple types of cancer. It has also developed proprietary drug discovery platform technologies in the areas of nano-medicines, 3D gold and times. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD.

Contact Information

Rexahn Pharmaceuticals, Inc.
15245 Shady Grove Road
Rockville Maryland 20850
P:(240) 268-5300
Investor Relations:



Mutual fund holders3.26%
Individual stakeholders10.67%
Other institutional0.70%

Top Executives

Chang Ho AhnChairman & Chief Scientist
Peter David SuzdakChief Executive Officer & Director
Rakesh SoniPresident & Chief Operating Officer
Tae Heum JeongChief Financial Officer, Secretary & Senior VP

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.